The Neurofilament Heavy Chain (NfHSMI35) in the Cerebrospinal Fluid Diagnosis of Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|21|5-6|291-295

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.21, Iss.5-6, 2006-05, pp. : 291-295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 33, Iss. 1, 2012-02 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

A Novel Panel of Cerebrospinal Fluid Biomarkers for the Differential Diagnosis of Alzheimer’s Disease versus Normal Aging and Frontotemporal Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 6, 2007-10 ,pp. : 434-440

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Tau Protein Levels and 18F-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 30, Iss. 3, 2010-09 ,pp. : 245-253

Karger

Access to resources Recommend Favorite

Genetic Association of CDC2 with Cerebrospinal Fluid Tau in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 20, Iss. 6, 2005-11 ,pp. : 367-374

Karger

Access to resources Recommend Favorite

Metal Concentrations in Plasma and Cerebrospinal Fluid in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 6, 2008-05 ,pp. : 508-515

Karger

Access to resources Recommend Favorite